Celebrex May Rely More On Pfizer Support During P&U/Monsanto Integration

The near-term performance of Searle/Pfizer's COX-2 inhibitor Celebrex (celecoxib) may rely more heavily on Pfizer's co-promotion efforts during a Pharmacia & Upjohn/Monsanto integration.